The results demonstrated that the number of infiltrated CD4+ cells in tumor tissue was significantly increased (p < 0.05) following treatment with GSE, showing a 15.79% rise compared to the SEC group (Figure 10B). The gene discussed is CD4; the disease is neoplasm.